Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Osteomyelitis — infection of bone — is among the most serious complications in podiatric medicine, occurring most commonly in diabetic patients with peripheral neuropathy and foot ulcers, but also following open fractures, surgical procedures, and puncture wounds. Once established, bone infection is difficult to eradicate without prolonged antibiotic therapy and often surgical intervention. Early, accurate diagnosis dramatically improves outcomes; delayed recognition allows infection to progress to abscess, osteonecrosis, and sepsis requiring amputation. Understanding the clinical presentation, diagnostic approach, and treatment principles of pedal osteomyelitis is essential for anyone managing foot wounds.

Pathophysiology and Risk Factors

Osteomyelitis reaches bone through three pathways: hematogenous spread (blood-borne infection seeding from a distant site — more common in children and immunocompromised patients), contiguous spread from an adjacent infected wound or soft tissue infection (the dominant mechanism in diabetic foot osteomyelitis), and direct inoculation from trauma or surgery. In diabetic foot osteomyelitis, chronic plantar ulcers overlying bony prominences (metatarsal heads, phalanges, heel) allow wound bacteria — predominantly Staphylococcus aureus, but polymicrobial in chronic wounds — direct access to the underlying cortical bone, progressing from periosteal infection to cortical and medullary involvement.

Risk factors for developing pedal osteomyelitis include: diabetes mellitus with peripheral neuropathy, peripheral arterial disease (ischemia impairs immune defense and healing), chronic non-healing ulcers greater than 2 cm², probe-to-bone test positive (metal probe touches bone during wound assessment), prior osteomyelitis, and immunosuppression from any cause.

Clinical Diagnosis

The probe-to-bone test is the most clinically important bedside maneuver: when a sterile metal probe inserted into a diabetic foot ulcer reaches bone directly, the probability of underlying osteomyelitis is approximately 89%. Clinical signs of erythema, warmth, swelling, and purulent drainage may be absent in neuropathic patients who cannot mount a normal inflammatory response. Systemic fever and leukocytosis are present in fewer than 50% of diabetic foot osteomyelitis cases — their absence should never be interpreted as ruling out infection.

Laboratory Assessment

Inflammatory markers — ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) — are elevated in most active osteomyelitis cases. An ESR greater than 70 mm/hr in a diabetic patient with a chronic ulcer has a positive predictive value of approximately 89% for osteomyelitis. Serial inflammatory markers track treatment response. Complete blood count and blood cultures are obtained when systemic infection is suspected.

Imaging

Plain X-rays may show periosteal reaction, cortical irregularity, or medullary lucency in established osteomyelitis — but these changes require 2–3 weeks of infection to become radiographically visible and are absent in early disease. MRI is the gold standard imaging modality for pedal osteomyelitis, demonstrating bone marrow edema (low T1/high STIR signal) with 90% sensitivity and 80% specificity — detectable within days of infection onset. CT provides superior cortical bone detail for surgical planning. Nuclear medicine bone and labeled WBC scans are useful adjuncts when MRI is contraindicated.

Treatment

Surgical Debridement

Surgical debridement — removal of infected, necrotic bone until margins are viable, bleeding tissue — is required in most chronic pedal osteomyelitis cases. Simple toe or ray amputations may be necessary for phalangeal osteomyelitis. Preservation of the metatarsal head is strongly preferable to resection, which creates altered forefoot biomechanics and shifts pressure to adjacent structures. Modern limb-salvage surgery priorities aim for the minimum bone resection that achieves viable margins.

Antibiotic Therapy

Following debridement and bone biopsy culture, targeted antibiotic therapy continues for 4–6 weeks for surgically debrided osteomyelitis, or 12 weeks for medical management without surgery. Antibiotic selection is guided by culture and sensitivity results. MRSA coverage (vancomycin, daptomycin, linezolid) is required when methicillin-resistant Staphylococcus aureus is identified or strongly suspected. Oral bioavailable agents (fluoroquinolones, rifampin combinations, linezolid) allow outpatient completion of antibiotic courses in stable patients.

Osteomyelitis — Foot Bone Infection Diagnosis & Treatment

Bone infections in the foot are serious complications that require prompt, aggressive treatment. Our podiatrists diagnose osteomyelitis using advanced imaging and lab testing, then coordinate antibiotic therapy and surgical debridement to save your limb and eliminate infection.

Learn About Diabetic Foot Complications | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369-379.
2. Lipsky BA, et al. Diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases. 2012;54(12):e132-e173.
3. Berendt AR, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes/Metabolism Research and Reviews. 2008;24(Suppl 1):S145-S161.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.